Sponsor Pipeline

Rocket Pharmaceuticals Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
10
Active Trials
5
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 2
2
Phase 1
2
Not specified
6
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06092034 A Gene Therapy Study of RP-A501 in Male Patients With Danon Disease Danon Disease Recruiting
NCT04248439 Gene Therapy for Fanconi Anemia, Complementation Group A Fanconi Anemia Complementation Group A Active, Not Recruiting
Phase 1
NCT05885412 A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated… PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) Recruiting
NCT07137338 A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in… Dilated Cardiomyopathy (DCM) Recruiting
Not specified
NCT06644742 PKP2-ACM Natural History Study Cardiomyopathies Recruiting
NCT06214507 Danon Disease Natural History Study Danon Disease Recruiting
NCT06282432 Long-Term Follow-Up (LTFU) for Gene Therapy of Leukocyte Adhesion Deficiency-I (LAD-I) Leukocyte Adhesion Deficiency Active, Not Recruiting
NCT07486752 BAG3-DCM Natural History Study Dilated Cardiomyopathy (DCM) Not Yet Recruiting
NCT04437771 Long-Term Follow-up of Subjects With Fanconi Anaemia Subtype A Treated With ex Vivo Gene… Fanconi Anemia Complementation Group A Active, Not Recruiting
NCT07527975 Long-Term Follow-up: Phase I/II Clinical Study to Evaluate the Safety and Efficacy of the… Fanconi Anemia Enrolling by Invitation
Disease Areas
Get alerts when Rocket Pharmaceuticals Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free